| Year | 2023 | 2022 |
|---|---|---|
| Total Revenue | 16.57B | 13.43B |
| Cost of Revenue | 13.4B | 5.51B |
| Gross Profit | 3.17B | 7.92B |
| Operating Expenses | 6.73B | 9.81B |
| Research and Development | 1.05B | 263.94M |
| Selling, General & Administrative Expenses | 2.21B | 1.63B |
| Selling & Marketing Expenses | 1.78B | 1.3B |
| General & Administrative Expenses | 432.93M | 333.22M |
| Other Expenses | 0 | 385.15M |
| Operating Income | -129.93M | -1.51B |
| Total Other Income/Expenses Net | -486.74M | -34.87M |
| Income Before Tax | -616.66M | -1.76B |
| Income Tax | 88.08M | 258.65M |
| Net Income | -704.74M | -2.02B |
| Basic EPS | -10.01 | -28.73 |
| EPS Diluted | -10.01 | -28.73 |
| Basic Average Shares | 70.4M | 70.39M |
| Diluted Average Shares | 70.4M | 70.39M |
| EBITDA | 742.36M | -466.67M |
Unichem Laboratories Limited
UNICHEMLAB.NS
NSE
570.85INR14.35 (-5.37%)
UNICHEMLAB.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 23.98B | 25.06B |
| Net Income | -704.74M | -2.02B |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -2.14M | -282.55M |
| Retained Earnings | 23.39B | 23.98B |
| Other Distributions | -586.43M | -1.37B |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 13.24B | 14.03B |
| Annual Depreciation | 1.13B | 1.13B |
| Capital Expenditure | -225.47M | -443.16M |
| Net PPE | 12.34B | 13.33B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 0 | 0 |
| Goodwill (Previous Year) | 15.45M | 15.45M |
| Goodwill | 15.45M | 15.45M |